+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tranquilizer"

Generic Central Nervous System Drugs Global Market Report 2024 - Product Thumbnail Image

Generic Central Nervous System Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

The tranquilizer market is a subset of the Central Nervous System (CNS) drugs market. Tranquilizers are drugs used to treat anxiety, insomnia, and other mental health conditions. They work by altering the levels of neurotransmitters in the brain, such as serotonin and dopamine, to reduce symptoms of anxiety and depression. Tranquilizers are typically prescribed for short-term use, as long-term use can lead to dependence and addiction. Tranquilizers are classified as either benzodiazepines or non-benzodiazepines. Benzodiazepines are the most commonly prescribed tranquilizers, and include drugs such as Valium and Xanax. Non-benzodiazepines are newer drugs, and include drugs such as Ambien and Lunesta. The tranquilizer market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Show Less Read more